[1] 中华医学会肝病学分会药物性肝病学组. 药物性肝损伤诊治指南. 中华肝脏病杂志, 2015, 23: 810-827.
[2] Yu YC, Mao YM, Chen CW, et al. CSH Guideline for the Diagnosis and Treatment of Drug-induced Liver Injury. Hepatol Int, 2017, 11: 221-241.
[3] Chalasani NP, Hayashi PH, Bonkovsky HL, et al. ACG Clinical Guideline: the diagnosis and management of idiosyncratic drug-induced liver injury. Am J Gastroenterol, 2014, 109: 950-966.
[4] 于乐成, 陈成伟. ACG特异质性药物性肝损伤临床诊治指南解读. 肝脏, 2014, 19: 570-574.
[5] 贾冬云, 蔡伯琴, 李学勤, 等. 慢乙肝患者健康教育效果评价. 护理学杂志, 2005, 20: 42-44.
[6] 冯辉, 何国平. 慢性乙型病毒性肝炎患者治疗依从性及其影响因素.中华护理杂志, 2005, 40: 891-894.
[7] 赵红, 范颖, 谢雯. 抗结核药物所致肝损伤临床研究进展. 现代医药卫生, 2018, 34: 1953-1955.
[8] 范晔,于乐成. 再谈中草药引起的药物性肝损伤. 现代医药卫生, 2018, 34: 1956-1958.
[9] 滕光菊,孙颖,常彬霞;等. 418例药物性肝损伤临床特征及预后分析. 肝脏, 2013,1:11-14.
[10] Miguel A, Azevedo LF, Arau JOM,et al.Frequency of adverse drug reactions in hospitalized patients: a systematic review and meta-analysis. Pharmacoepidemiol Drug Saf, 2012, 21: 1139- 1154.
[11] 于乐成, 范晔, 陈成伟. 药物性肝损伤再刺激试验:能否故意?如何操作?如何判断?肝脏, 2017, 22: 1073-1076.
[12] 于乐成, 范晔, 陈成伟. 药物性肝损伤的诊断和治疗. 临床肝胆病杂志, 2018, 34: 193-198. |
